Unilife Corporation designs, manufactures, and supplies injectable drug delivery systems in the United States. The company has a portfolio of proprietary product platforms, including pre-filled syringes, drug reconstitution delivery systems, auto-injectors, wearable injectors, ocular delivery systems and other injectable drug delivery systems. The company sells its products directly to pharmaceutical and biotechnology companies who incorporate them into the drug-device combination product that is supplied pre-filled and ready for administration by end-users, such as health-care providers or patients. Product Platforms The company has developed a portfolio of injectable drug delivery systems that are designed for use with a range of injectable therapies. Existing and prospective customers can select from a series of platform-based technologies, including pre-filled syringes, wearable injectors, auto-injectors, drug reconstitution systems and ocular delivery systems. Pre-filled Syringes The Unifill platform is designed to accommodate the majority of injectable therapies suitable for containment in a single-chamber pre-filled syringe for administration via routes, including subcutaneous injection, intramuscular injection, or intravenous infusion. The majority of products within the Unifill platform include an automatic, user-controlled needle retraction mechanism designed to protect those at risk of needlestick injuries. Product configurations within the Unifill platform include Unifill, a pre-filled syringe with integrated, automatic and user-controlled retraction; Unifill Finesse, a combining integrated, automatic and user-controlled retraction with a standard plunger seal and plunger rod; Unifill Select, which allows the end-user to select and attach a needle at the time of injection, with automatic, user-controlled needle retraction; Unifill Nexus, which is equipped with an integrated luer adapter to provide universal connectivity with needleless luer access devices; and Unifill Allure, which is combining universal luer connectivity with automatic, user-controlled needle retraction. Wearable Injectors The ReadyToGo platform of wearable injectors is designed to support demand for pre-filled, disposable devices that can be worn by a patient over periods, such as several minutes or several hours during the subcutaneous injection of therapies, such as viscous, large-dose volume biologics. The company’s wearable injectors are designed for supply by pharmaceutical and biotechnology companies and are pre-filled, pre-assembled and ready-to inject for simple and convenient self-injection by a patient outside of healthcare facilities, to minimize disruption to normal daily life during the period of therapy administration. Features of the company’s wearable injectors include a soft Flexwear catheter that is automatically inserted into the body for patient comfort during an injection, and a user interface with visual and audible signals that inform the user during each stage of use. Auto-Injectors The company has a platform of disposable and reusable auto-injectors that are designed for use with pre-filled syringes from its Unifill platform. Its auto-injectors can be customized to address specific customer, therapy, patient or commercial requirements, product configurations with, including LISA smart reusable auto-injector; and RITA disposable auto-injector. LISA Smart Reusable Auto-Injector: An automated and highly customizable product that can be used by a patient to perform various injections. Patients can control the speed of dose delivery to help minimize pain or discomfort during an injection. It allows for the removal of a used Unifill syringe with a retracted needle for disposal. Other features include a single activation button, LED indicators and a push on skin sensor to minimize potential drug wastage. Customization options include Bluetooth connectivity. RITA Disposable Auto-Injector: An ergonomic single-use product with minimal steps of use and no visible springs or mechanisms. An audible, tactile click signals the delivery of the full dose to minimize potential drug wastage.
unilife corp-cdi (UNISZ:Grey Market)
250 Cross Farm Lane
York, PA 17406
|Becton Dickinson and Co||$141.94 USD||-0.47|
|West Pharmaceutical Services Inc||$55.13 USD||+0.45|
|Ypsomed Holding AG||SFr.93.25 CHF||-0.15|
|View Industry Companies|
|Price/Cash Flow||--||Not Meaningful|
Sponsored Financial Commentaries
To contact UNILIFE CORP-CDI, please visit www.unilife.com. Company data is provided by Capital IQ. Please use this form to report any data issues.